Your browser doesn't support javascript.
loading
Humoral response rate and predictors of response to BNT162b2 mRNA COVID19 vaccine in patients with multiple myeloma.
Avivi, Irit; Balaban, Roi; Shragai, Tamir; Sheffer, Gabi; Morales, Miguel; Aharon, Anat; Lowenton-Spier, Noa; Trestman, Svetlana; Perry, Chava; Benyamini, Noam; Mittelman, Moshe; Tabib, Yaara; Bar Lev, Tali; Zavaro, Mor; Herishanu, Yair; Luttwak, Efrat; Cohen, Yael C.
Afiliación
  • Avivi I; Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Balaban R; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Shragai T; Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Sheffer G; Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Morales M; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Aharon A; Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Lowenton-Spier N; Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Trestman S; Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Perry C; Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Benyamini N; Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Mittelman M; Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Tabib Y; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Bar Lev T; Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Zavaro M; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Herishanu Y; Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Luttwak E; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Cohen YC; Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Br J Haematol ; 195(2): 186-193, 2021 10.
Article en En | MEDLINE | ID: mdl-34196388
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunidad Humoral / Vacunas contra la COVID-19 / COVID-19 / Vacuna BNT162 / Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Año: 2021 Tipo del documento: Article País de afiliación: Israel
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunidad Humoral / Vacunas contra la COVID-19 / COVID-19 / Vacuna BNT162 / Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Año: 2021 Tipo del documento: Article País de afiliación: Israel